Maxi Investments CY Ltd Takes $1.66 Million Position in Danaher Corporation $DHR

Maxi Investments CY Ltd acquired a new stake in shares of Danaher Corporation (NYSE:DHR) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,300 shares of the conglomerate’s stock, valued at approximately $1,656,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Portland Investment Counsel Inc. purchased a new stake in Danaher during the 2nd quarter valued at $11,934,000. Cibc World Market Inc. bought a new position in shares of Danaher during the 2nd quarter valued at $31,830,000. Satovsky Asset Management LLC purchased a new position in shares of Danaher in the 2nd quarter worth $355,000. Blue Whale Capital LLP bought a new stake in shares of Danaher in the second quarter worth $17,508,000. Finally, OMERS ADMINISTRATION Corp purchased a new position in Danaher in the second quarter worth about $6,729,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Up 0.3%

DHR stock opened at $219.42 on Monday. The business’s 50-day moving average price is $195.80 and its 200-day moving average price is $192.40. The stock has a market cap of $154.25 billion, a P/E ratio of 38.97, a PEG ratio of 2.72 and a beta of 0.78. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80.

Danaher (NYSE:DHR) last released its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The company had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. During the same period in the prior year, the firm posted $0.77 EPS. The firm’s quarterly revenue was up 5.5% compared to the same quarter last year. On average, equities research analysts forecast that Danaher Corporation will post 8.53 EPS for the current year.

Analyst Ratings Changes

DHR has been the subject of a number of recent research reports. DZ Bank started coverage on Danaher in a research note on Wednesday, June 3rd. They set a “buy” rating and a $210.00 price target for the company. HSBC lowered their price objective on shares of Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a research note on Wednesday, June 3rd. Weiss Ratings upgraded shares of Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, July 15th. Royal Bank Of Canada upped their target price on shares of Danaher from $200.00 to $215.00 and gave the company an “outperform” rating in a report on Wednesday, July 22nd. Finally, Stifel Nicolaus decreased their price target on shares of Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a research report on Wednesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $228.91.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.